| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.28 | 7e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |